α9β1 Integrin in melanoma cells can signal different adhesion states for migration and anchorage

Experimental Cell Research

Volumn 315, Issue 19, 2009, Pages 3312-3324

  Lydolph, Magnus C ^a   Morgan Fisher, Marie ^a   Høye, Anette M ^a   Couchman, John R ^a   Wewer, Ulla M ^a   Yoneda, Atsuko ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ADAM12; Cell migration; Cytoskeleton; Focal adhesion; Small GTPase; 9 1 integrin

Indexed keywords

ADAM PROTEIN; ALPHA9BETA1 INTEGRIN; BETA1 INTEGRIN; CELL SURFACE RECEPTOR; MANGANESE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RAC PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; TENASCIN; UNCLASSIFIED DRUG; INTEGRIN; INTEGRIN ALPHA 9 BETA 1; PROTEIN SUBUNIT;

ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; ENDOSOME; EXTRACELLULAR MATRIX; FOCAL ADHESION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MELANOMA; MELANOMA CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRESS FIBER; CELL CULTURE; CELL MOTION; CYTOLOGY; MELANOCYTE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; FOCAL ADHESIONS; HUMANS; INTEGRINS; MANGANESE; MELANOCYTES; MELANOMA; PROTEIN SUBUNITS; SIGNAL TRANSDUCTION;

EID: 70350411154     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.09.022     Document Type: Article

References (59)

1. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
2. Arias-Salgado E.G., Lizano S., Sarkar S., Brugge J.S., Ginsberg M.H., and Shattil S.J. Src kinase activation by direct interaction with the integrin β cytoplasmic domain. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13298-13302
3. Liu S., Calderwood D.A., and Ginsberg M.H. Integrin cytoplasmic domain-binding proteins. J. Cell Sci. 113 (2000) 3563-3571
4. Luo B.H., Carman C.V., and Springer T.A. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25 (2007) 619-647
5. Palmer E.L., Rüegg C., Ferrando R., Pytela R., and Sheppard D. Sequence and tissue distribution of the integrin α9 subunit, a novel partner of β1 that is widely distributed in epithelia and muscle. J. Cell Biol. 123 (1993) 1289-1297
6. Yokosaki Y., Palmer E.L., Prieto A.L., Crossin K.L., Bourdon M.A., Pytela R., and Sheppard D. The integrin α9β1 mediates cell attachment to a non-RGD site in the third fibronectin type-III repeat of tenascin. J. Biol. Chem. 269 (1994) 26691-26696
7. Lu X., Lu D., Scully M.F., and Kakkar V.V. Structure-activity relationship studies on ADAM protein-integrin interactions. Cardiovasc. Hematol. Agents Med. Chem. 5 (2007) 29-42
8. Thodeti C.K., Fröhlich C., Nielsen C.K., Holck P., Sundberg C., Kveiborg M., Mahalingam Y., Albrechtsen R., Couchman J.R., and Wewer U.M. Hierarchy of ADAM12 binding to integrins in tumor cells. Exp. Cell Res. 309 (2005) 438-450
9. Shinde A.V., Bystroff C., Wang C., Vogelezang M.G., Vincent P.A., Hynes R.O., and Van De Water L. Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin α9β1-dependent cellular activities. J. Biol. Chem. 283 (2008) 2858-2870
10. Taooka Y., Chen J., Yednock T., and Sheppard D. The integrin α9β1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J. Cell Biol. 145 (1999) 413-420
11. Huang X.Z., Wu J.F., Ferrando R., Lee J.H., Wang Y.L., Farese Jr. R.V., and Sheppard D. Fatal bilateral chylothorax in mice lacking the integrin α9β1. Mol. Cell. Biol. 20 (2000) 5208-5215
12. Chen C., Huang X., Atakilit A., Zhu Q.S., Corey S.J., and Sheppard D. The Integrin α9β1 contributes to granulopoiesis by enhancing granulocyte colony-stimulating factor receptor signaling. Immunity 25 (2006) 895-906
13. Rao H., Lu G., Kajiya H., Garcia-Palacios V., Kurihara N., Anderson J., Patrene K., Sheppard D., Blair H.C., Windle J.J., Choi S.J., and Roodman G.D. α9β1: a novel osteoclast integrin that regulates osteoclast formation and function. J. Bone Miner. Res. 21 (2006) 1657-1665
14. Singh P., Reimer C.L., Peters J.H., Stepp M.A., Hynes R.O., and Van De Water L. The spatial and temporal expression patterns of integrin α9β1 and one of its ligands, the EIIIA segment of fibronectin, in cutaneous wound healing. J. Invest. Dermatol. 123 (2004) 1176-1181
15. Gulubova M., and Vlaykova T. Immunohistochemical assessment of fibronectin and tenascin and their integrin receptors α5β1 and α9β1 in gastric and colorectal cancers with lymph node and liver metastases. Acta Histochem. 108 (2006) 25-35
16. Brown M.C., Staniszewska I., Lazarovici P., Tuszynski G.P., Del Valle L., and Marcinkiewicz C. Regulatory effect of nerve growth factor in α9β1 integrin-dependent progression of glioblastoma. Neuro Oncol. 10 (2008) 968-980
17. Xu L., Shen S.S., Hoshida Y., Subramanian A., Ross K., Brunet J.P., Wagner S.N., Ramaswamy S., Mesirov J.P., and Hynes R.O. Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol. Cancer Res. 6 (2008) 760-769
18. Ilmonen S., Jahkola T., Turunen J.P., Muhonen T., and Asko-Seljavaara S. Tenascin-C in primary malignant melanoma of the skin. Histopathology 45 (2004) 405-411
19. Wang A., Yokosaki Y., Ferrando R., Balmes J., and Sheppard D. Differential regulation of airway epithelial integrins by growth factors. Am. J. Respir. Cell Mol. Biol. 15 (1996) 664-672
20. Prieto A.L., Edelman G.M., and Crossin K.L. Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10154-10158
21. Gilpin B.J., Loechel F., Mattei M.G., Engvall E., Albrechtsen R., and Wewer U.M. A novel, secreted form of human ADAM 12 (meltrin α) provokes myogenesis in vivo. J. Biol. Chem 273 (1998) 157-166
22. Ren X.D., Kiosses W.B., and Schwartz M.A. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18 (1999) 578-585
23. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., and Horwitz A.R. Cell migration: integrating signals from front to back. Science 302 (2003) 1704-1709
24. Eto K., Puzon-McLaughlin W., Sheppard D., Sehara-Fujisawa A., Zhang X.P., and Takada Y. RGD-independent binding of integrin α9β1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction. J. Biol. Chem. 275 (2000) 34922-34930
25. Huang J., Bridges L.C., and White J.M. Selective modulation of integrin-mediated cell migration by distinct ADAM family members. Mol. Biol. Cell 16 (2005) 4982-4991
26. Mostafavi-Pour Z., Askari J.A., Parkinson S.J., Parker P.J., Ng T.T., and Humphries M.J. Integrin-specific signaling pathways controlling focal adhesion formation and cell migration. J. Cell Biol. 161 (2003) 155-167
27. Iba K., Albrechtsen R., Gilpin B., Fröhlich C., Loechel F., Zolkiewska A., Ishiguro K., Kojima T., Liu W., Langford J.K., Sanderson R.D., Brakebusch C., Fässler R., and Wewer U.M. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to β1 integrin-dependent cell spreading. J. Cell Biol. 149 (2000) 1143-1156
28. Mahalingam Y., Gallagher J.T., and Couchman J.R. Cellular adhesion responses to the heparin-binding (HepII) domain of fibronectin require heparan sulfate with specific properties. J. Biol. Chem. 282 (2007) 3221-3230
29. Riento K., and Ridley A.J. Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell Biol 4 (2003) 446-456
30. Ishizaki T., Uehata M., Tamechika I., Keel J., Nonomura K., Maekawa M., and Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol. Pharmacol. 57 (2000) 976-983
31. Frame M.C. Newest findings on the oldest oncogene; how activated src does it. J. Cell Sci. 117 (2004) 989-998
32. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., and Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271 (1996) 695-701
33. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., Mclauchlan H., Klevernic I., Arthur J.S., Alessi D.R., and Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408 (2007) 297-315
34. Tatton L., Morley G.M., Chopra R., and Khwaja A. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. J. Biol. Chem. 278 (2003) 4847-4853
35. Price L.S., Leng J., Schwartz M.A., and Bokoch G.M. Activation of Rac and Cdc42 by integrins mediates cell spreading. Mol. Biol. Cell 9 (1998) 1863-1871
36. Del Pozo M.A., Kiosses W.B., Alderson N.B., Meller N., Hahn K.M., and Schwartz M.A. Integrins regulate GTP-Rac localized effector interactions through dissociation of Rho-GDI. Nat. Cell Biol. 4 (2002) 232-239
37. Vidali L., Chen F., Cicchetti G., Ohta Y., and Kwiatkowski D.J. Rac1-null mouse embryonic fibroblasts are motile and respond to platelet-derived growth factor. Mol. Biol. Cell 17 (2006) 2377-2390
38. Gao Y., Dickerson J.B., Guo F., Zheng J., and Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7618-7623
39. Shutes A., Onesto C., Picard V., Leblond B., Schweighoffer F., and Der C.J. Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. J. Biol. Chem. 282 (2007) 35666-35678
40. Liu L., Schwartz B.R., Lin N., Winn R.K., and Harlan J.M. Requirement for RhoA kinase activation in leukocyte de-adhesion. J. Immunol. 169 (2002) 2330-2336
41. Vogelsgesang M., Pautsch A., and Aktories K. C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins. Naunyn-Schmiedebergs Arch. Pharmacol. 374 (2007) 347-360
42. Jones M.C., Caswell P.T., and Norman J.C. Endocytic recycling pathways: emerging regulators of cell migration. Curr. Opin. Cell Biol. 18 (2006) 549-557
43. Ramsay A.G., Marshall J.F., and Hart I.R. Integrin trafficking and its role in cancer metastasis. Cancer Metastasis Rev. 26 (2007) 567-578
44. Hiebsch R.R., Raub T.J., and Wattenberg B.W. Primaquine blocks transport by inhibiting the formation of functional transport vesicles. Studies in a cell-free assay of protein transport through the Golgi apparatus. J. Biol. Chem. 266 (1991) 20323-20328
45. van Weert A.W., Geuze H.J., Groothuis B., and Stoorvogel W. Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes. Eur. J. Cell Biol. 79 (2000) 394-399
46. Roberts M., Barry S., Woods A., van der Sluijs P., and Norman J. PDGF-regulated rab4-dependent recycling of αvβ3 integrin from early endosomes is necessary for cell adhesion and spreading. Curr. Biol. 11 (2001) 1392-1402
47. Morgan M.R., Humphries M.J., and Bass M.D. Synergistic control of cell adhesion by integrins and syndecans. Nat. Rev. Mol. Cell Biol. 8 (2007) 957-969
48. Madsen C.D., and Sidenius N. The interaction between urokinase receptor and vitronectin in cell adhesion and signalling. Eur. J. Cell Biol. 87 (2008) 617-629
49. Ng T., Shima D., Squire A., Bastiaens P.I., Gschmeissner S., Humphries M.J., and Parker P.J. PKCα regulates β1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J. 18 (1999) 3909-3923
50. Ivaska J., Vuoriluoto K., Huovinen T., Izawa I., Inagaki M., and Parker P.J. PKCe{open}-mediated phosphorylation of vimentin controls integrin recycling and motility. EMBO J. 24 (2005) 3834-3845
51. Clark K., Pankov R., Travis M.A., Askari J.A., Mould A.P., Craig S.E., Newham P., Yamada K.M., and Humphries M.J. A specific α5β1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation. J. Cell Sci. 118 (2005) 291-300
52. Stanley P., Smith A., McDowall A., Nicol A., Zicha D., and Hogg N. Intermediate-affinity LFA-1 binds α-actinin-1 to control migration at the leading edge of the T cell. EMBO J. 27 (2008) 62-75
53. Humphries J.D., Schofield N.R., Mostafavi-Pour Z., Green L.J., Garratt A.N., Mould A.P., and Humphries M.J. Dual functionality of the anti-β1 integrin antibody, 12G10, exemplifies agonistic signalling from the ligand binding pocket of integrin adhesion receptors. J. Biol. Chem. 280 (2005) 10234-10243
54. Young B.A., Taooka Y., Liu S., Askins K.J., Yokosaki Y., Thomas S.M., and Sheppard D. The cytoplasmic domain of the integrin α9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner. Mol. Biol. Cell 12 (2001) 3214-3225
55. Liu S., Slepak M., and Ginsberg M.H. Binding of paxillin to the α9 integrin cytoplasmic domain inhibits cell spreading. J. Biol. Chem. 276 (2001) 37086-37092
56. Brown M.C., and Turner C.E. Paxillin: adapting to change. Physiol. Rev. 84 (2004) 1315-1339
57. deHart G.W., Jin T., McCloskey D.E., Pegg A.E., and Sheppard D. The α9β1 integrin enhances cell migration by polyamine-mediated modulation of an inward-rectifier potassium channel. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 7188-7193
58. Ridley A.J. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16 (2006) 522-529
59. Adams J.C., and Watt F.M. Changes in keratinocyte adhesion during terminal differentiation: reduction in fibronectin binding precedes α5β1-integrin loss from the cell-surface. Cell 63 (1990) 425-435